2 Method is Faster and Reliable. Stroke [Internet]

52

DAFTAR PUSTAKA

1.

Bornstein NM. Stroke Practical Guide for Clinicians Bornstein NM. Switzerland: Karger; 2009. 9-23 p.

2.

RI BP dan PKKK. Riset Kesehatan Dasar 2013. Jakarta; 2013.

3.

Widyono. Profil Kesehatan Kota Semarang 2014 [Internet]. Semarang; 2014. Available from: www.dinkes-kotasemarang.go.id

4.

Mohr, JP, Philip A Wolf JCG. Stroke Pathophysiology, Diagnosis and Management. Elsevier Saunders. Philadelphia; 2011. 295-307 p.

5.

Martin JH. Neuroanatomy Text and Atlas. 3rd ed. Mc Graw Hill; 2003.

6.

Chong TT-J, Fedi M. Acute management of stroke – II: haemorrhagic stroke. Anaesth Intensive Care Med [Internet]. 2013;14(9):366–70. Available

from:

http://linkinghub.elsevier.com/retrieve/pii/S1472029913001975 7.

Zis P, Leivadeas P, Michas D, Kravaritis D, Angelidakis P, Tavernarakis A. Predicting 30-day case fatality of primary inoperable intracerebral hemorrhage based on findings at the emergency department. J Stroke Cerebrovasc Dis [Internet]. 2014 Aug 8;23(7):1928–33. Available from: http://www.strokejournal.org/article/S1052305714000664/fulltext

8.

Hanifah, Dinna, Dyan Roshinta Laksmi Dewi SNYRSA. Pengaruh Volume Perdarahan dan Skor Glasgow Coma Scale (GCS) Saat Masuk Rumah Sakit Terhadap Kejadian Mortalitas Pada Pasien Stroke Perdarahan Intraserebral Di RSUD DR. Soedarso Pontianak. 2015;1:1689–99.

9.

WJ Powers JJ. Stroke Overview. Elsevier Saunders. Philadelphia; 2014.

10.

Zazulia A. Intracerebral Hemorrhage, Primary. Elsevier Saunders. Philadelphia; 2014.

11.

Kleinman JT, Jordan LC, Hillis AE. ABC/2: estimating intracerebral haemorrhage volume and total brain volume and predicting outcome in children. Dev Med Child Neurol. 2010;

53

12.

Kumar A, Shetty V. Abstract W P330: Intracerebral Hemorrhage Volume Measurement: Modified ABC/2 Method is Faster and Reliable. Stroke [Internet]. 2015 Feb 1;46(Suppl_1):AWP330 – . Available from: http://stroke.ahajournals.org/content/46/Suppl_1/AWP330

13.

Harrison JK, McArthur KS, Quinn TJ. Assessment scales in stroke: clinimetric and clinical considerations. Clin Interv Aging [Internet]. 2013;8:201–11.

Available

from:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578502/ 14.

Budiyono T. Hubungan Derajat Berat Stroke Non Hemoragik pada saat Masuk Rumah Sakit dengan Waktu Pencapaian Maksimal Aktifitas Kehidupan Sehari-hari. Universitas Diponegoro; 2005.

15.

Wihartantie A, dr. Retno Dwi Danarti SRO. Hubungan Perdarahan Intraserebral Dan Glasgow Coma Scale Pada Stroke Dengan Pemeriksaan Multiclice

Computed

Tomography

Scan.

2011;

Available

from:

http://etd.repository.ugm.ac.id/index.php?mod=penelitian_detail&sub=Pen elitianDetail&act=view&typ=html&buku_id=53536 16.

Singh AJ, Pmr DNB. CT Scan as a Tool for Predicting Outcome of Stroke due

to

Intracerebral

Haemorrhage

at

a

Referral

Hospital.

2006;17(October):33–8. 17.

Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, Molina C a., Blas YS, Dzialowski I, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): A prospective observational study. Lancet Neurol [Internet].

2012;11(4):307–14.

Available

from:

http://dx.doi.org/10.1016/S1474-4422(12)70038-8 18.

Ritarwan K. Pengaruh Suhu Tubuh Terhadap Outcome Penderita Stroke Yang Dirawat Di RSUP H. Adam Malik Medan. 2003;1–30.

19.

Kim K-H. Predictors of 30-day mortality and 90-day functional recovery after primary intracerebral hemorrhage : hospital based multivariate analysis in 585 patients. J Korean Neurosurg Soc [Internet]. 2009 Jun;45(6):341–9.

Available

from:

54

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2711231&tool= pmcentrez&rendertype=abstract 20.

Joarder M, Karim A, Barua K, Hossain M. A study on-effect of hematoma and perihematomal edema volume on GCS at the time of admission in patients with spontaneous lobar and basal ganglia hemorrhage. Pulse [Internet].

2015

May

7;7(1):22.

Available

from:

http://www.banglajol.info/index.php/PULSE/article/view/23246 21.

Rea P. Essential Clinical Anatomy of The Nervous System. Academic Press; 2015. 4 p.

22.

David S Liebeskind M. Hemorrhagic Stroke: Practice Essentials, Background, Anatomy. Medscape [Internet]. 2015; Available from: http://emedicine.medscape.com/article/1916662-overview

23.

Sidharta P DG. Anatomi Susunan Saraf Pusat Manusia. Jakarta: Dian Rakyat; 1986. 398 p.

24.

J G. Basic Neurology 3rd Edition. 3rd ed. New York: McGraw-Hill; 2000.

25.

Layanto A. Hubungan Antara Lokasi Lesi Pada Penderita Stroke Iskemik Fase Akut Dengan Waktu Perawatan Dan Waktu Kematian Dalam 30 Hari Pertama. Universitas Diponegoro Semarang; 2009.

26.

Tubbs RS. Circle of Willis Anatomy: Overview, Gross Anatomy, Natural Variants.

Medscape

[Internet].

2013;

Available

from:

http://emedicine.medscape.com/article/1877617-overview 27.

Cristy. Asosiasi Genotip Apolipoprotein E Dengan Fungsi Kognitif Pada Pasien Pasca Stroke Iskemik. Universitas Diponegoro Semarang; 2011.

28.

Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet [Internet]. 2008

May

10;371(9624):1612–23.

Available

from:

http://www.thelancet.com/article/S0140673608606947/fulltext 29.

Smith EE, Liang L, Hernandez a., Reeves MJ, Cannon CP, Fonarow GC, et al. Influence of stroke subtype on quality of care in the Get with the Guidelines-Stroke Program. Neurology. 2009;73(9):709–16.

30.

Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJB, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for

55

healthcare professionals from the American Heart Association/American Stroke Association. Stroke [Internet]. 2013 Jul;44(7):2064–89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23652265 31.

Soeharto

I.

Penyakit

Jantung

Koroner

dan

Serangan

Jantung :

Pencegahan,Penyembuhan, Rehabilitasi. Jakarta: PT Gramedia Pustaka; 2004. 32.

Saenger AK, Christenson RH. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem [Internet].

2010

Jan;56(1):21–33.

Available

from:

http://www.ncbi.nlm.nih.gov/pubmed/19926776 33.

Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35(11 SUPPL. 1):2620–2.

34.

Zebian B, Critchley G. Spontaneous intracranial haemorrhage. Surgery [Internet].

2012;30(3):136–41.

Available

from:

http://dx.doi.org/10.1016/j.mpsur.2011.12.005 35.

LR C. Caplan’s Stroke : A Clinical Approach. 3rd ed. Boston: ButterworthHeineman; 2000.

36.

Quinones-Hinojosa A. Schmidek & sweet Operative Neurosurgical Techniques Indications, Methods, and Results. 2nd ed. Philadelphia: Elsevier; 2012.

37.

Chan S, Hemphill JC. Critical Care Management of Intracerebral Hemorrhage. Crit Care Clin [Internet]. 2014;30(4):699–717. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0749070414000499

38.

Alberti A, Agnelli G, Caso V, Venti M, Acciarresi M, D’Amore C, et al. Non-neurological complications of acute stroke: frequency and influence on clinical outcome. Intern Emerg Med. 2011;6(S1):119–23.

39.

Bonaiuti D, Sioli P, Fumagalli L, Beghi E, Agostoni E. Acute medical complications in patients admitted to a stroke unit and safe transfer to rehabilitation. Neurol Sci [Internet]. 2011;32(4):619–23. Available from: http://link.springer.com/10.1007/s10072-011-0588-2

40.

Zimmerman RD, Maldjian JA, Brun NC, Horvath B, Skolnick BE.

56

Radiologic estimation of hematoma volume in intracerebral hemorrhage trial by CT scan. AJNR Am J Neuroradiol [Internet]. 2006 Mar;27(3):666– 70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16552014 41.

Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of Intracerebral Hemorrhage A Powerful and Easy-to-Use Predictor of 30-Day Mortality. 1988;

42.

Setiahardja AS. Penilaian Keseimbangan dengan Aktivitas Kehidupan Sehari-hari pada Lansia. Universitas Diponegoro; 2005.

43.

Isaac E. MDS. Hemorrhagic Stroke: An Atlas of Investigation and Treatment. Clinical Publishing; 2010.

44.

Yasaka M, Sakata T, Minematsu K, Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res. 2002;108(1):25–30.

45.

Nag C, Das K, Ghosh M, Khandakar MR. Prediction of clinical outcome in acute hemorrhagic stroke from a single CT scan on admission. N Am J Med Sci. 2012;4(10):463–7.

46.

Anggiamurni L. Hubungan Volume Dan Letak Lesi Hematoma Dengan Kecepatan Pemulihan Fungsi Motorik Penderita Stroke Hemoragik Berdasarkan Kategori Skala Orgogozo. Universitas Diponegoro; 2010.

47.

Castellanos M, Leira R, Tejada J, Gil-Peralta A, Dávalos A, Castillo J, et al. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry [Internet].

2005

May;76(5):691–5.

Available

from:


Molshatzki N, Orion D, Tsabari R, Schwammenthal Y, Merzeliak O, Toashi M, et al. Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome. Cerebrovasc

Dis

[Internet].

2011;31(3):271–7.

Available

from:


Bagg S, Pombo AP, Hopman W. Effect of Age on Functional Outcomes After Stroke Rehabilitation. Stroke [Internet]. 2002 Jan 1;33(1):179–85.

57

Available

from:

http://stroke.ahajournals.org/cgi/doi/10.1161/hs0102.101224 50.

Yu C, An Z, Zhao W, Wang W, Gao C, Liu S, et al. Sex Differences in Stroke Subtypes, Severity, Risk Factors, and Outcomes among Elderly Patients with Acute Ischemic Stroke. Front Aging Neurosci [Internet]. 2015;7:174.

Available

from:


Saxena A, Anderson CS, Wang X, Sato S, Arima H, Chan E, et al. Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage.

Stroke

26;47(3):STROKEAHA.115.011627.

[Internet].

2016 Available

Jan from:

http://stroke.ahajournals.org/lookup/doi/10.1161/STROKEAHA.115.01162 7 52.

Iqbal M, Frida M, Yaswir R. Perbedaan Rerata Kadar Gula Darah pada Luaran Stroke Iskemik Berdasarkan Indeks Barthel. J Kesehat Andalas. 2014;3(3).

53.

Karunawan NH, Pinzon RT, Saputro SA. Pengaruh Kondisi Hiperglikemia Saat Masuk RS terhadap Luaran Fungsional Pasien Stroke Iskemik di RS Bethesda. Cermin Dunia Kedokt. 2016;43(2):87–90.

54.

Kurube I. Stroke Hemoragik Pada Pasien Yang Dirawat Di RSUP Dr . Wahidin Sudirohusodo Periode Juli 2012- Desember 2012. 2013;

55.

Susilo TA. Pengaruh Hiperglikemia Terhadap Mortalitas Pada Penderita Stroke Iskemik Fase Akut Di Rsud Dr. Moewardi. 2015;

56.

Greer DM, Funk SE, Reaven NL, Ouzounelli M, Uman GC. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke [Internet]. 2008 Nov;39(11):3029–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18723420

57.

El-solh A, Sikka P, Bozkanat E, Jaafar W. Morbid Obesity in the Medical ICU Morbid Obesity in the Medical ICU. October. 2007;1989–97.

58.

Marlina I, Dr. dr. Ismail Setyopranoto SS. Skor Perdarahan Intraventrikel Sebagai Prediktor Mortalitas Pada Pasien Stroke Perdarahan Intraserebral.

58

2013. 59.

Chen G, Arima H, Wu G, Heeley E, Delcourt C, Zhang P, et al. Subarachnoid extension of intracerebral hemorrhage and 90-day outcomes in INTERACT2. Stroke [Internet]. 2014 Jan;45(1):258–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24149007

59

Lampiran 1. Ethichal Clearance

60

Lampiran 2. Surat Ijin Penelitian

61

62

63

Lampiran 3. Data Hasil Pengukuran

No CM

Usia

Jenis

Hipertensi Diabetes Hiperkolesterolemia Obesitas

kelamin

SAH

IVH

Melitus

Volume

Barthel

perdarahan

Index

C550543

55 tahun

laki-laki

Ya

Tidak

Tidak

Tidak

Tidak Tidak

80

0

A567266

48 tahun

laki-laki

Tidak

Tidak

Tidak

Ya

Tidak Tidak

10,28

38

C563832

78 tahun

laki-laki

Ya

Ya

Tidak

Tidak

Tidak Tidak

14,22

20

C540047

63 tahun

laki-laki

Ya

Tidak

Tidak

Tidak

Tidak Tidak

16,8

0

C579201

40 tahun perempuan

Ya

Ya

Ya

Tidak

Tidak Tidak

45

0

C542601

48 tahun perempuan

Ya

Tidak

Tidak

Tidak

Tidak Tidak

18,66

20

C568878

74 tahun perempuan

Ya

Ya

Ya

Tidak

Tidak Tidak

30,75

0

C540566

50 tahun perempuan

Ya

Ya

Tidak

Tidak

Tidak Tidak

18,36

35

C586734

60 tahun perempuan

Ya

Tidak

Ya

Tidak

Tidak Tidak

26

19

64

C585587

58 tahun perempuan

Ya

Tidak

Ya

Ya

Tidak Tidak

60,35

59

B244140

47 tahun

laki-laki

Tidak

Tidak

Ya

Tidak

Tidak Tidak

58,3

20

C569284

46 tahun

laki-laki

Ya

Tidak

Tidak

Ya

Ya

Tidak

46,76

100

C578053

64 tahun perempuan

Tidak

Ya

Ya

Tidak

Ya

Tidak

1,94

20

C573334

61 tahun perempuan

Ya

Ya

Ya

Ya

Tidak

Ya

15,85

20

C567418

84 tahun perempuan

Tidak

Tidak

Tidak

Tidak

11

14

C566529

70 tahun

laki-laki

Tidak

Tidak

Tidak

Tidak

Ya

Tidak

63

20

C574728

54 tahun

Laki-laki

Tidak

Ya

Tidak

Tidak

Tidak

Ya

23,3

20

C575938

52 tahun perempuan

Ya

Tidak

Tidak

Tidak

Tidak Tidak

51,76

0

C572627

66 tahun

laki-laki

Tidak

Ya

Tidak

Tidak

Ya

Ya

10,64

19

C57834

62 tahun

laki-laki

Ya

Tidak

Tidak

Tidak

Tidak

Ya

32

6

C573545

46 tahun perempuan

Ya

Ya

Ya

Tidak

Tidak Tidak

17,87

0

Tidak Tidak

65

C366230

55 tahun perempuan

Ya

Ya

Tidak

Ya

C586775

61 tahun perempuan

Ya

Tidak

Tidak

Tidak

Tidak Tidak

C565083

61 tahun

Ya

Ya

Tidak

Tidak

Tidak

B260516

74 tahun perempuan

Ya

Tidak

Ya

Tidak

C572827

74 tahun perempuan

Ya

Tidak

Tidak

C510142

46 tahun perempuan

Ya

Tidak

C567202

52 tahun perempuan

Ya

C576094

57 tahun

Ya

laki-laki

laki-laki

Tidak

Ya

44,46

17

48,02

32

74

0

Tidak Tidak

1,29

20

Tidak

Tidak Tidak

39

17

Ya

Ya

Tidak Tidak

19,21

19

Ya

Ya

Ya

Tidak Tidak

5,6

0

Tidak

Tidak

Ya

Tidak

0,42

51

Ya

Ya

66

Lampiran 4. Hasil Analisa Statistik

Frequencies

Frequency Table

Jenis kel amin

Valid

Laki-laki Perempuan Total

Frequency 12 17 29

Percent 41.4 58.6 100.0

Valid Percent 41.4 58.6 100.0

Cumulat iv e Percent 41.4 100.0

Hipertensi

Valid

Ya Tidak Total

Frequency 22 7 29

Percent 75.9 24.1 100.0



DM

Valid

Ya Tidak Total

Frequency 12 17 29

Percent 41.4 58.6 100.0



Hiperkolesterolemi a

Valid

Ya Tidak Total

Frequency 11 18 29

Percent 37.9 62.1 100.0



67

Obesitas

Valid

Ya Tidak Total

Frequency 8 21 29

Percent 27.6 72.4 100.0



SAH

Valid

Ya Tidak Total

Frequency 4 25 29

Percent 13.8 86.2 100.0



IVH

Valid

Ya Tidak Total

Frequency 7 22 29

Percent 24.1 75.9 100.0



Barthel Index

Valid

Total Berat Mandiri Total

Frequency 23 5 1 29

Percent 79.3 17.2 3.4 100.0

Valid Percent 79.3 17.2 3.4 100.0

Cumulat iv e Percent 79.3 96.6 100.0

68

Explore

Case Summaries Usia N Mean St d. Dev iation Median Minimum Maximum

29 58.83 11.000 58.00 40 84

Volume perdarahan 29 30.51 22.565 23.30 0 80

Bart hel I ndex 29 20.21 21.569 19.00 0 100

Tests of Normality

Usia Volume perdarahan Bart hel I ndex

St at ist ic .963 .933 .773

Shapiro-Wilk df 29 29 29

Sig. .382 .065 .000

a. Lillief ors Signif icance Correction

Nonparametric Correlations

Correlati ons

Spearman's rho

Usia

Volume perdarahan

Bart hel I ndex

Correlation Coef f icient Sig. (2-tailed) N Correlation Coef f icient Sig. (2-tailed) N Correlation Coef f icient Sig. (2-tailed) N

Usia 1.000 . 29 -.200 .299 29 -.074 .704 29

Volume perdarahan -.200 .299 29 1.000 . 29 -.165 .391 29

Bart hel I ndex -.074 .704 29 -.165 .391 29 1.000 . 29

69

Graph

Graph

70

Crosstabs

Jenis kelamin * Barthel Index

Crosstab

Jenis kelamin

Laki-laki

Perempuan

Total

Count Expected Count % wit hin Barthel Index Count Expected Count % wit hin Barthel Index Count Expected Count % wit hin Barthel Index

Bart hel Index Total Berat /Mandiri 9 3 9.5 2.5 39.1% 50.0% 14 3 13.5 3.5 60.9% 50.0% 23 6 23.0 6.0 100.0% 100.0%

Total 12 12.0 41.4% 17 17.0 58.6% 29 29.0 100.0%

Chi-Square Tests

Pearson Chi-Square Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value .232b .000 .229

.224

df 1 1 1

1

Asy mp. Sig. (2-sided) .630 .987 .632

Exact Sig. (2-sided)


.669

.487

.636

29

a. Computed only f or a 2x2 table b. 2 cells (50.0%) hav e expect ed count less than 5. The minimum expected count is 2. 48.

71

Hipertensi * Barthel Index

Crosstab

Hipertensi

Ya

Tidak

Total

Bart hel I ndex Total Berat /Mandiri 17 5 17.4 4.6 73.9% 83.3% 6 1 5.6 1.4 26.1% 16.7% 23 6 23.0 6.0 100.0% 100.0%


Total 22 22.0 75.9% 7 7.0 24.1% 29 29.0 100.0%

Chi-Square Tests


Value .231b .000 .245

.223

df 1 1 1

1

Asy mp. Sig. (2-sided) .631 1.000 .620



1.000

.545

.637

29


72

DM * Barthel Index

Crosstab

DM

Ya

Tidak

Total



Total 12 12.0 41.4% 17 17.0 58.6% 29 29.0 100.0%

Chi-Square Tests


Value 1.905b .837 2.088

1.839

df 1 1 1

1

Asy mp. Sig. (2-sided) .168 .360 .148



.354

.182

.175

29


73

Hiperkolesterolemia * Barthel Index

Crosstab

Hiperkolesterolemia

Ya

Tidak

Total


Bart hel Index Total Berat /Mandiri 10 1 8.7 2.3 43.5% 16.7% 13 5 14.3 3.7 56.5% 83.3% 23 6 23.0 6.0 100.0% 100.0%

Total 11 11.0 37.9% 18 18.0 62.1% 29 29.0 100.0%

Chi-Square Tests


Value 1.453b .537 1.597

1.403

df 1 1 1

1

Asy mp. Sig. (2-sided) .228 .464 .206



.362

.237

.236

29


74

Obesitas * Barthel Index

Crosstab

Obesitas

Ya

Tidak

Total



Total 8 8.0 27.6% 21 21.0 72.4% 29 29.0 100.0%

Chi-Square Tests


Value 5.784b 3.580 5.270

5.585

df 1 1 1

1

Asy mp. Sig. (2-sided) .016 .058 .022



.033

.033

.018

29


75

SAH * Barthel Index

Crosstab

SAH

Ya

Tidak

Total

Bart hel I ndex Total Berat /Mandiri 3 1 3.2 .8 13.0% 16.7% 20 5 19.8 5.2 87.0% 83.3% 23 6 23.0 6.0 100.0% 100.0%


Total 4 4.0 13.8% 25 25.0 86.2% 29 29.0 100.0%

Chi-Square Tests


Value .053b .000 .051

.051

df 1 1 1

1

Asy mp. Sig. (2-sided) .819 1.000 .822



1.000

.627

.822

29

a. Computed only f or a 2x2 table b. 2 cells (50.0%) hav e expect ed count less than 5. The minimum expected count is . 83.

76

IVH * Barthel Index

Crosstab

IVH

Ya

Tidak

Total



Total 7 7.0 24.1% 22 22.0 75.9% 29 29.0 100.0%

Chi-Square Tests


Value .231b .000 .245

.223

df 1 1 1

1

Asy mp. Sig. (2-sided) .631 1.000 .620



1.000

.545

.637

29


77

Explore

Barthel Index

Case Summaries Usia Bart hel I ndex Total Berat /Mandiri Total

N 23 6 29

Mean 60.26 53.33 58.83

Std. Dev iat ion 11.624 6.121 11.000

Median 61.00 53.50 58.00

Tests of Normal ity

Usia

Bart hel I ndex Total Berat /Mandiri

St at ist ic .972 .912

Shapiro-Wilk df 23 6


Usia

Sig. .746 .448

Minimum 40 46 40

Maximum 84 61 84

78

T-Test

Group Statistics

Usia


N 23 6

Mean 60.26 53.33

Std. Dev iat ion 11.624 6.121

Std. Error Mean 2.424 2.499

Independent Samples Test

Lev ene's Test f or Equality of Variances t-t est f or Equality of Means

Usia Equal v ariances Equal v ariances assumed not assumed 2.179 .151 1.397 1.990 27 15.679 .174 .064

F Sig. t df Sig. (2-tailed) Mean Dif f erence St d. Error Dif f erence 95% Conf idence Interv al of the Dif f erence

Lower Upper

6.928

6.928

4.959

3.481

-3.248 17.103

-.465 14.320

79

Explore

Case Summaries Volume perdarahan Bart hel I ndex Total Berat /Mandiri Total

N 23 6 29

Mean 30.46 30.70 30.51

Std. Dev iat ion 22.697 24.179 22.565

Median 23.30 32.56 23.30

Minimum 1 0 0

Tests of Normal ity

Volume perdarahan



Shapiro-Wilk Stat istic df .923 23 .912 6

Sig. .076 .450

Maximum 80 60 80

80

T-Test

Group Statisti cs

Volume perdarahan

Bart hel Index Total Berat /Mandiri

N 23 6

Mean 30.46 30.70

St d. Dev iation 22.697 24.179

St d. Error Mean 4.733 9.871

Independent Samples Test

Lev ene's Test f or Equality of Variances t-t est f or Equality of Means

Volume perdarahan Equal v ariances Equal v ariances assumed not assumed .207 .652 -.022 -.021 27 7.473 .982 .983

F Sig. t df Sig. (2-tailed) Mean Dif f erence St d. Error Dif f erence 95% Conf idence Interv al of the Dif f erence

Lower Upper

-.235

-.235

10.534

10.947

-21.849 21.378

-25.792 25.322

81

Logistic Regression

Block 1: Method = Backward Stepwise (Likelihood Ratio)

Classification Tablea Predicted

St ep 1

Observ ed Bart hel I ndex

St ep 2

Ov erall Percentage Bart hel I ndex

St ep 3


St ep 4


St ep 5


St ep 6


St ep 7

Ov erall Percentage Bart hel I ndex Ov erall Percentage

a. The cut v alue is .500

Total Berat /Mandiri

Bart hel I ndex Total Berat /Mandiri 22 1 3 3


22 3

1 3


22 3

1 3


22 3

1 3


22 3

1 3


22 3

1 3


22 3

1 3

Percentage Correct 95.7 50.0 86.2 95.7 50.0 86.2 95.7 50.0 86.2 95.7 50.0 86.2 95.7 50.0 86.2 95.7 50.0 86.2 95.7 50.0 86.2

82

Variables in the Equation

Step a 1

Step a 2

Step a 3

Step a 4

Step a 5

Step a 6

Step a 7

Usia sex Hipertensi DM Hiperkolesterolemia Obesitas SAH Vol_perdarahan Constant Usia sex Hipertensi DM Hiperkolesterolemia Obesitas SAH Constant Usia sex Hipertensi DM Hiperkolesterolemia Obesitas Constant Usia sex DM Hiperkolesterolemia Obesitas Constant Usia DM Hiperkolesterolemia Obesitas Constant DM Hiperkolesterolemia Obesitas Constant Hiperkolesterolemia Obesitas Constant

B -.056 .966 -.314 1.709 2.874 -2.915 -.379 .000 -1.846 -.055 .968 -.321 1.711 2.873 -2.910 -.391 -1.816 -.056 .904 -.277 1.711 2.881 -2.922 -2.506 -.058 .971 1.716 2.877 -2.913 -2.809 -.061 1.479 2.374 -2.719 -.062 1.553 2.322 -3.188 -2.842 2.455 -3.075 -.608

S.E. .077 1.619 2.069 1.573 1.830 1.594 2.704 .030 8.587 .076 1.619 2.008 1.568 1.829 1.564 2.596 8.346 .076 1.544 2.012 1.570 1.827 1.560 6.831 .073 1.463 1.558 1.812 1.544 6.317 .077 1.415 1.587 1.463 4.908 1.427 1.586 1.414 3.351 1.511 1.321 2.441

Wald .526 .356 .023 1.180 2.466 3.344 .020 .000 .046 .529 .357 .026 1.190 2.469 3.462 .023 .047 .533 .343 .019 1.188 2.488 3.507 .135 .631 .440 1.213 2.522 3.559 .198 .621 1.093 2.238 3.452 .000 1.183 2.144 5.088 .719 2.639 5.420 .062

df 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Sig. .468 .551 .879 .277 .116 .067 .888 .988 .830 .467 .550 .873 .275 .116 .063 .880 .828 .465 .558 .890 .276 .115 .061 .714 .427 .507 .271 .112 .059 .656 .431 .296 .135 .063 .990 .277 .143 .024 .396 .104 .020 .803

Exp(B) .946 2.628 .731 5.523 17.711 .054 .684 1.000 .158 .946 2.632 .725 5.532 17.693 .054 .676 .163 .946 2.470 .758 5.537 17.834 .054 .082 .944 2.640 5.561 17.768 .054 .060 .941 4.387 10.742 .066 .940 4.725 10.193 .041 .058 11.645 .046 .545

95.0% C.I.for EXP(B) Lower Upper .814 1.099 .110 62.809 .013 42.149 .253 120.615 .490 640.149 .002 1.233 .003 136.951 .943 1.062 .815 .110 .014 .256 .491 .003 .004

1.099 62.798 37.127 119.558 637.215 1.168 109.608

.815 .120 .015 .255 .497 .003

1.098 50.923 39.103 120.115 639.751 1.146

.818 .150 .262 .510 .003

1.089 46.428 117.840 619.415 1.120

.809 .274 .479 .004

1.095 70.184 240.989 1.161

.288 .456 .003

77.506 228.086 .658

.602 .003

225.157 .615

a. Variable(s) entered on step 1: Usia, sex, Hipertensi, DM, Hiperkolesterolemia, Obesitas, SAH, Vol_perdarahan.

83

Lampiran 5. Biodata Mahasiswa Identitas Nama

: Ahda Amila Sholiha

NIM

: 22010112130198

Tempat/tanggal lahir : Grobogan, 22 November 1993 Jenis kelamin

: Perempuan

Alamat

: Jalan Pondok Dustira 234A Sukamaju Padasuka RT9 RW6 Cimahi Tengah 40526

Nomor telepon

: (022)-6610418

Nomor HP

: 087832840125

e-mail

: [email protected]

Riwayat Pendidikan Formal 1. 2. 3. 4.

SD SMP SMA FK UNDIP

: MI Asih Putera : SMP Negeri 2 Cimahi : SMA Negeri 2 Cimahi : Masuk tahun : 2012

Lulus tahun : 2005 Lulus tahun : 2008 Lulus tahun : 2011

Keanggotaan Organisasi 1. Eksekutif muda EKOBIS BEM KM FK UNDIP tahun 2014 2. Staf departemen KSKI ROHIS KU UNDIP tahun 2013 sampai 2014 3. Anggota KSM KU UNDIP tahun 2013 sampai 2014

2 Method is Faster and Reliable. Stroke [Internet]

Recommend Documents